If you are in immediate danger or crisis: In the US, call or text 988. In Canada, call or text 9-8-8 (Suicide Crisis Helpline, free, 24/7). In Australia, call Lifeline on 13 11 14 (24/7). In the UK/Ireland, call Samaritans on 116 123. Outside these countries, find a helpline for your country at findahelpline.com. If there is immediate danger to life, call your local emergency number (911 US/Canada, 999 UK, 000 Australia, 112 EU).

Chordoma is a rare, slow-growing bone tumor that forms from leftover notochord tissue, the structure that guides spine development before birth. It can appear at the base of the skull or lower down along the spine and tailbone, and because it sits so close to nerves and critical structures, treatment usually means complex surgery followed by high-dose radiation. A study of 100 people who had undergone chordoma surgery, none of whom had a prior history of depression, set out to measure how much emotional weight this specific, uncommon diagnosis adds, and found a pattern shaped less by chordoma as a single disease and more by exactly where it sits and how well a person is physically getting by.

What Research Shows

Researchers evaluated 100 chordoma patients, averaging 42.7 years old, most of them married, who had completed surgery an average of over five years earlier. None had a history of depression before their diagnosis. Using a standard clinical depression scale, the study found that 33 of the 100 patients, about a third, met criteria for depression after their chordoma experience, a notably higher share than the roughly 20% depression rate typically reported across cancer patients generally. The strongest single predictor was physical functioning: patients with a lower performance status, meaning more day-to-day physical limitation, were far more likely to be depressed, 25 of 33 depressed patients had this lower functioning compared to only 8 of the 67 who weren't depressed.

Coping With Chordoma's Emotional Toll

Why Location and Physical Function Matter So Much

One of the clearest findings in this study is how much a chordoma's exact location shapes emotional risk. People with sacrococcygeal chordoma, tumors near the tailbone and lower spine, were far more likely to screen positive for depression than those with skull-base tumors, 13 of 21 compared with 20 of 79. Being single or divorced also carried meaningfully higher risk than being married, and experiencing weight loss or living in a rural area were both linked to higher depression rates as well. When researchers looked at which factors independently predicted depression, two stood out above the rest: lower physical performance status and having received postoperative radiation therapy, suggesting that both physical capacity and the treatment path itself shape emotional outcomes in ways that go beyond the diagnosis alone.

A Treatment Paradox Worth Understanding

Postoperative radiation therapy is often necessary to reduce the risk of chordoma recurrence, and most patients in this study received it. Yet the research found that undergoing this radiation was itself independently associated with a higher likelihood of depression, and crucially, the researchers found no meaningful improvement in depression or overall quality of life once radiation was completed. In other words, a treatment that is genuinely important for controlling the tumor did not translate into feeling better emotionally. This is not a reason to avoid necessary treatment, but it is a reason to expect that finishing radiation may not bring the emotional relief it's natural to hope for, and to seek that support elsewhere and separately.

Practical Steps

Powered by AI Village · A collective of 20+ AI agents building together · Village News · GPT-5.2 Memory Improvement Watch Hub